We are live on
!
Find out more
ECP
Elk Creek Partners Portfolio holdings
AUM
$582M
1-Year Est. Return
10.23%
This Fund
S&P 500
This Quarter
Est. Return
+3.24%
1 Year Est. Return
-10.23%
3 Year Est. Return
+16.39%
5 Year Est. Return
+41.52%
10 Year Est. Return
–
AUM
$1.34B
AUM Growth
-$48.8M
(-3.5%)
Cap. Flow
-$46.2M
Cap. Flow
% of AUM
-3.45%
Top 10 Holdings %
Top 10 Hldgs %
22.05%
Holding
140
New
8
Increased
36
Reduced
80
Closed
16
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Heron Therapeutics
HRTX
|
+$13.3M |
| 2 |
HOME
At Home Group Inc.
HOME
|
+$11M |
| 3 |
CLVS
Clovis Oncology, Inc.
CLVS
|
+$9.49M |
| 4 |
Verra Mobility
VRRM
|
+$8.01M |
| 5 |
Yeti Holdings
YETI
|
+$7.97M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RCM
R1 RCM Inc. Common Stock
RCM
|
+$17.2M |
| 2 |
EFII
Electronics for Imaging
EFII
|
+$16.9M |
| 3 |
ADSW
Advanced Disposal Services Inc
ADSW
|
+$12.8M |
| 4 |
MDCO
Medicines Co
MDCO
|
+$12.6M |
| 5 |
QTNA
Quantenna Communications, Inc. Common Stock
QTNA
|
+$11.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.27% |
| 2 | Technology | 15.92% |
| 3 | Industrials | 15.31% |
| 4 | Communication Services | 11.67% |
| 5 | Consumer Discretionary | 11.27% |
Similar funds
BAC
AVC
OWD
PP
WWM
JA
PL
EA
Elk Creek Partners's Q2 2019 Portfolio in Review
As of Q2 2019, Elk Creek Partners held 140 positions worth $1.34B, down 3.5% from $1.39B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Elk Creek Partners withdrew a net $46.2M in Q2 2019, closing 16 positions and reducing 80 holdings. Its most notable exit was R1 RCM Inc. Common Stock, an estimated $17.2M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 22% a quarter earlier, followed by Technology and Industrials.
Against the trend, Elk Creek Partners opened a new position in Heron Therapeutics worth $12.4M.
- Elk Creek Partners's largest Q2 2019 buy was Heron Therapeutics: 668,240 shares worth $12.4M.
- Elk Creek Partners added most to Clovis Oncology, Inc. in Q2 2019, an estimated $9.49M increase.
- Elk Creek Partners's biggest Q2 2019 reduction was Electronics for Imaging, cutting an estimated $16.9M.
- Elk Creek Partners fully exited R1 RCM Inc. Common Stock in Q2 2019, selling an estimated $17.2M.
- Elk Creek Partners's ten largest holdings make up 22% of its $1.34B portfolio in Q2 2019.
- Elk Creek Partners opened 8 new positions and closed 16 in Q2 2019.
- Elk Creek Partners's portfolio value fell 3.5% quarter-over-quarter to $1.34B.
Based on Elk Creek Partners's 13F filing for Q2 2019, filed 9 Aug 2019.